The Testing and Analysis Center of Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd. (hereinafter referred to as “Lewwin Testing and Analysis Center”) is a testing platform under Guangdong Lewwin Pharmaceutical Research Institute Co., Ltd. Relying on the institute, the center conducts testing and analysis of new cosmetic ingredients and finished products. It possesses the necessary professional personnel, facilities, equipment, and testing experience, with a core team boasting over 20 years of industry background. The service quality is excellent, data are secure and reliable, and it can provide clients with professional, comprehensive technical solutions. Lewwin Testing and Analysis Center has obtained CMA and GLP qualifications in the cosmetic field and can carry out professional testing services for products such as special cosmetics and general cosmetics.
● Testing Services
In accordance with the requirements of the “Regulations on the Supervision and Administration of Cosmetics,” following the GLP system and CMA system operation management, and referencing the “Technical Standards for Cosmetic Safety,” “Technical Guidelines for Cosmetic Safety Assessment,” national standards, or internationally accepted methods, testing services are provided.
Lewwin Pharm Cosmetic Evaluation Platform has obtained OECD GLP Certification, US FDA GLP Certification, AAALAC International Full Accreditation, national CMA Accreditation (China Metrology Accreditation), and qualification as an testing and analysis agency for cosmetic registration and filing authorized by the National Medical Products Administration. We can support global regulatory submissions for general cosmetics, new cosmetic ingredients, and special-use cosmetics.
● Testing Services
Principles of Pathology
Test Item
Standard or Guideline
Acute Oral Toxicity Study
OCED401
Technical Standards for Cosmetic Safety/Technical Guidelines for Cosmetic Safety Assessment
Acute Dermal Toxicity Study
OECD402
Acute Inhalation Toxicity Study
OECD403
Subchronic Oral Toxicity Study
OECD408
Subchronic Dermal Toxicity Study
OECD410
28-Day Repeated Dose Oral Toxicity Study
OECD407
28-Day Repeated Dose Inhalation Toxicity Study
OECD412
90-Day Repeated Dose Inhalation Toxicity Study
OECD413
Combined Chronic Toxicity/Carcinogenicity Test
OECD453
Skin Irritation/Corrosion Test
OECD404
Acute Eye Irritation/Corrosion Test
OECD405
Skin Sensitization Test
OECD406
Bacterial Reverse Mutation Test
OECD471
In Vitro Mammalian Chromosome Aberration Test
OECD473
In Vitro Mammalian Cell Gene Mutation Test
OECD476
Mammalian Bone Marrow Chromosome Aberration Test
OECD475
In Vivo Mammalian Micronucleus Test
OECD474
In Vitro Mammalian Micronucleus Test
OECD487
Extended One-Generation Reproductive Toxicity Study
OECD443
Two-Generation Reproductive Toxicity Study
OECD416
Skin Phototoxicity Test
-
In Vitro Skin Sensitization
Skin Phototoxicity Test
Skin Absorption In Vivo Test
Testicular Germ Cell Chromosome Aberration Test
Teratogenicity Test
In Vivo Comet Assay
◆ Efficacy Claim Evaluation
● Testing Services
Efficacy Evaluation
Efficacy Evaluation
Test Model
Test Indicator
Standard or Guideline
Spot Removal and Whitening
Human Melanoma Cells
Melanin Protein Content, Tyrosinase Activity, Melanin-Related Gene Expression